Chronic fatigue syndrome (ME/CFS)
The condition long COVID's fatigue-and-PEM cluster most resembles, and the source of its pacing playbook.
Most people recover from COVID-19 within weeks. For a significant minority, symptoms persist for months or years: fatigue that rest doesn't fix, a mind that won't clear, a heart that races on standing, pain that moves around the body. Long COVID is real, biologically grounded, and still being worked out by science. Here is what's known, what's still hypothesis, and what genuinely helps today.
What is long COVID?
Long COVID, also called post-COVID-19 condition or PASC, is a chronic condition that follows SARS-CoV-2 infection, with symptoms present around three months from infection and lasting at least two months, not explained by another diagnosis. Common symptoms include fatigue, post-exertional malaise, brain fog, breathlessness, palpitations, and pain. It is real, biologically grounded, and heterogeneous. Careful, symptom-directed care already helps.
No single mechanism explains every case. Research points to several overlapping processes, and which ones dominate in you shapes what kind of help fits.
Long COVID is the persistence or emergence of symptoms after a SARS-CoV-2 infection, beyond the time the acute illness should have resolved. Two formal definitions are in wide use, and they agree on the essentials:
In medical records it is coded ICD-10 U09.9, or 'post COVID-19 condition, unspecified.' You may also see the research term PASC (post-acute sequelae of SARS-CoV-2 infection). All of these names describe the same thing: a real, diagnosable condition, not a wastebasket label.
The 'not explained by an alternative diagnosis' clause matters in both directions. It means clinicians should rule out other treatable causes. It also means that once they have, persistent symptoms deserve to be taken at face value rather than re-litigated at every appointment.
More than 200 symptoms have been documented across organ systems. In practice, most people's illness is dominated by one or more recognizable clusters:
| Cluster | Typical symptoms |
|---|---|
| Fatigue / ME-CFS-like | Profound fatigue not relieved by rest; post-exertional malaise (symptoms crash 12–72 hours after exertion); unrefreshing sleep |
| Cognitive ('brain fog') | Poor concentration and word-finding, slowed thinking, memory lapses, often worse when fatigued or upright for long periods |
| Autonomic / dysautonomia | Racing heart on standing, palpitations, dizziness or lightheadedness, temperature and blood-pressure instability (POTS included) |
| Pain | Widespread muscle and joint pain, headaches, chest wall pain, nerve-type pain, sometimes migrating and fluctuating |
| Cardiorespiratory | Breathlessness, exercise intolerance, cough, chest tightness |
| Other | Loss or distortion of smell and taste, gastrointestinal symptoms, new allergies or intolerances, mood and sleep disturbance |
Two features are worth underlining. First, the course typically fluctuates, with good days and bad days and flares after physical, cognitive, or emotional exertion. Second, the clusters overlap: many people have symptoms from several at once, and the mix can shift over months. That heterogeneity is one reason a single 'long COVID treatment' doesn't exist. Care has to be matched to the phenotype in front of the clinician.
The numbers are large. In CDC Household Pulse Survey data from 2024, about 7% of U.S. adults, roughly 17 million people, reported currently having long COVID. A major 2023 review in Nature Reviews Microbiology estimated the condition follows at least ~10% of SARS-CoV-2 infections, with tens of millions affected worldwide. Estimates vary with definitions and methods, but by any of them, this is one of the most common chronic conditions to emerge in decades.
No single cause has been established, and it is unlikely that one ever will be. Long COVID probably names several overlapping disease processes. The leading hypotheses, each with supporting evidence and open questions:
These are not competing explanations so much as candidate contributors that may combine differently in different people. The practical upshot: be wary of anyone, clinician or influencer, who claims to know *the* cause of long COVID or sells *the* cure. Equally, don't mistake scientific uncertainty about mechanism for uncertainty about reality. The condition is real. The explanation is a work in progress.
Long COVID is not a nervous-system condition wholesale. For two of its major symptom clusters, though, the nervous system is squarely where the evidence points.
Postural orthostatic tachycardia syndrome (POTS) is one of the best-documented post-COVID diagnoses: an abnormal rise in heart rate on standing, with dizziness, palpitations, and fatigue. A large 2022 study in Nature Cardiovascular Research found new POTS diagnoses were substantially more likely after SARS-CoV-2 infection than in comparison periods. Dysautonomia has recognizable patterns, testable findings (such as a stand test or tilt-table test), and established management strategies, which is why it's worth asking about specifically if your symptoms surge when you're upright. The overlap with chronic dizziness is substantial.
For post-COVID pain that persists after tissue has healed and workup is reassuring, pain researchers (notably Fernández-de-las-Peñas and colleagues) have proposed phenotyping it as nociceptive, neuropathic, or nociplastic: pain driven by a sensitized pain system rather than ongoing damage. Sensitization-associated symptoms are common in people with post-COVID pain. The framing matters because nociplastic pain responds to different tools than tissue-directed treatments: pain neuroscience education, graded activity, and nervous-system-directed retraining. This is the same mechanism explained in our guides to central sensitization and neuroplastic pain.
The careful version of the claim: central sensitization is one cited contributor to some long COVID symptoms, especially persistent pain, and not an explanation for the whole condition. If widespread, moving pain is a prominent part of your picture, our neuroplastic pain quiz can help you see whether your pain fits the sensitization pattern worth raising with your clinician.
Post-exertional malaise (PEM) is a delayed crash: a marked worsening of fatigue, cognition, pain, and flu-like symptoms, typically 12 to 72 hours after physical, cognitive, or emotional exertion, often out of all proportion to the effort and lasting days or longer. It is the hallmark symptom of myalgic encephalomyelitis / chronic fatigue syndrome, and it is very common in long COVID. In a large international patient-led study of long-haulers published in The Lancet's EClinicalMedicine, the great majority of respondents reported it.
PEM changes the rules of rehabilitation. For most chronic conditions, including most chronic pain, gradually increasing activity is helpful, and 'hurt does not equal harm.' In the PEM phenotype, that logic can fail: exertion beyond the person's current capacity doesn't build fitness, it triggers crashes that can lower the ceiling further. This is why the UK's NICE guideline on managing the long-term effects of COVID-19 directs clinicians to screen for PEM *before* prescribing exercise, and why people with prominent PEM are managed with pacing rather than pushed, incremental exercise programs.
The practical rule: match the approach to the phenotype. Symptoms that flare *during* activity and settle quickly often tolerate graded activity well. A delayed, day-later crash pattern is a signal to pace rather than push, and to say so explicitly to any clinician or trainer designing your program.
Long COVID is usually fluctuating rather than dangerous. Some symptoms, though, should never be filed under it without urgent assessment, because they can signal cardiac, clotting, lung, or neurological problems that need immediate treatment:
None of this contradicts the reality of long COVID. It reflects how good care works: dangerous explanations get ruled out first, and a positive diagnosis is made on the pattern that remains.
There is no single confirmatory test. Diagnosis is clinical: a history of probable or confirmed SARS-CoV-2 infection, a compatible symptom pattern lasting three months or more, and reasonable exclusion of alternative explanations. Under the NASEM 2024 definition, a positive test from the original infection is not required. Many people, especially from early waves, never had access to testing.
A sensible workup is targeted to your symptoms rather than exhaustive. Depending on the picture, it may include:
Two things are worth knowing going in. Normal test results are common in long COVID and do not mean nothing is wrong, because routine tests were not designed to detect the mechanisms under study. Second, a good clinician treats the workup as a step toward a positive diagnosis and a plan, not a verdict on your credibility.
There is not yet a cure or a disease-modifying drug proven for long COVID, though trials are ongoing. 'No cure yet' does not mean 'nothing helps.' Current care is symptom-directed rehabilitation, and done well it meaningfully improves function and quality of life for many people:
Approach anything marketed directly to long COVID patients, whether supplements or unproven infusions or expensive protocols, with the same skepticism the mechanisms deserve. If it claims to fix everything, it has skipped ahead of the science. Never start, stop, or change medications except in conversation with your prescriber.
See a clinician promptly, and urgently for the red flags above. Beyond emergencies, make an appointment if:
If your appointments have felt dismissive, persistence is justified: long COVID has formal definitions, a diagnostic code, and a large research effort behind it. Bring a symptom diary, note what triggers flares and how long they last, and ask directly how your clinician approaches post-COVID care, or for a referral to someone who has made it a focus.
Yes, unambiguously. It has a WHO clinical case definition, a 2024 National Academies definition, its own ICD-10 code (U09.9), and a large body of published research documenting biological findings in affected patients. Uncertainty about *mechanisms* is real, and it is not the same as uncertainty about whether the condition exists.
It varies widely. Many people improve substantially over the first year. Others remain ill for years, and the course is typically relapsing-and-remitting rather than steady. Honest answer: there is no reliable way to predict an individual's trajectory yet.
What is known is that management choices matter along the way. Avoiding repeated push-crash cycles in the PEM phenotype, treating dysautonomia, and rehabilitating sensitized pain all improve the day-to-day experience while research continues.
Yes. Long COVID follows mild and even asymptomatic infections, not just hospitalizations. Most people with long COVID had an acute illness they managed at home. Severity of the acute infection raises the risk but is not required, which is one reason the condition was underestimated early on.
They overlap but aren't identical. A substantial subset of people with long COVID meet diagnostic criteria for ME/CFS, the cluster marked by profound fatigue, unrefreshing sleep, and post-exertional malaise. For that subset, the hard-won lessons of ME/CFS care, above all pacing, apply directly.
Long COVID is broader, though. It also includes phenotypes dominated by dysautonomia, pain, breathlessness, or organ-specific problems that are not ME/CFS. That's why phenotyping, figuring out which clusters describe *you*, is the most useful step in getting matched to the right care.
It depends entirely on the phenotype, and this is the most important nuance in long COVID rehabilitation. If you experience post-exertional malaise, meaning delayed crashes after exertion, guidelines advise pacing within your energy envelope, not incremental exercise programs, because pushing through can trigger lasting setbacks.
If you do not have PEM, carefully graded, symptom-matched activity is generally helpful and is part of standard rehabilitation, including for the sensitized-pain phenotype. The screening question, per NICE guidance, should come before any exercise prescription.
Not wholesale, and this site won't tell you otherwise. Long COVID is heterogeneous, and leading mechanistic hypotheses include viral persistence, immune dysregulation, and vascular changes alongside nervous-system processes.
The defensible, evidence-cited link is narrower: for persistent post-COVID pain, central sensitization is one documented contributor, and researchers recommend phenotyping such pain as nociplastic when it fits that pattern, because sensitized pain responds to nervous-system-directed rehabilitation. If pain is a major part of your long COVID, that's the thread worth exploring with your clinician.
U09.9, or 'post COVID-19 condition, unspecified.' It was created specifically so that long COVID could be documented, tracked, and billed as its own diagnosis. Clinicians often pair it with codes for the specific manifestations, such as POTS, chronic fatigue, or chronic pain. Coding is your clinician's call. This is here so your paperwork makes sense.
Talk with our care team about your pain, your history, and whether KVET™ is right for you. Free, and from the comfort of home.